| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0004 | 1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.00061 | 1 |